148.55USD+0.33%Mkt Cap: 8.38B $P/E: 165.061d ago
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fib…
Industry Peers
Medical Instruments & Supplies$142.49BUSDP/E 48.8
$84.67BUSDP/E 34.0
$73.25BUSDP/E 36.1
$44.07BUSDP/E 27.9
$31.69BUSDP/E 42.2
$29.41BUSDP/E 19.6
$25.61BUSDP/E 48.5
$19.82BUSDP/E 67.9
$18.23BUSDP/E 44.9
$18.54BUSDP/E 105.1
$14.74BUSDP/E 83.6
$13.59BUSDP/E 44.2
$14.26BUSDP/E 61.9
$14.15BUSDP/E 10.0
$12.78BUSDP/E 30.0
$12.06BUSD
$8.60BUSDP/E 23.1
$7.69BUSD
$5.63BUSDP/E 23.0
$5.99BUSDP/E 1931.7
$4.53BUSDP/E 30.5
$4.51BUSDP/E 32.6
$4.46BUSD
$4.39BUSDP/E 65.8
$4.03BUSDP/E 40.3
$4.05BUSDP/E 87.2
$3.67BUSDP/E 16.5
$3.32BUSDP/E 21.4
$3.39BUSDP/E 2759.0
$2.85BUSDP/E 21.9
$2.63BUSD
$2.77BUSD
$2.35BUSDP/E 37.9
$1.95BUSDP/E 36.0
$1.89BUSD
$1.80BUSD
$1.48BUSD
$1.44BUSD
$1.29BUSDP/E 74.9
$1.41BUSD
$1.23BUSD
$1.09BUSD
$752.64MUSDP/E 16.0
$811.83MUSD
$756.96MUSDP/E 14.8
$671.62MUSDP/E 39.2
$660.94MUSDP/E 55.9
$584.44MUSD
$360.76MUSDP/E 21.2
$354.68MUSDP/E 17.1
$272.64MUSD
$245.88MUSDP/E 13.6
$232.03MUSDP/E 422.0
$211.00MUSDP/E 35.6
$228.42MUSDP/E 21.2
$198.25MUSDP/E 23.8
$198.75MUSDP/E 1.8
$194.76MUSD
$188.63MUSDP/E 16.3
$160.12MUSD
$164.06MUSD
$123.68MUSDP/E 39.3
$115.11MUSD
$120.22MUSD
$107.50MUSD
$61.36MUSDP/E 6.4
$59.94MUSD
$48.70MUSD
$40.82MUSDP/E 53.7
$41.23MUSDP/E 41.0
$37.15MUSD
$32.43MUSD
$26.84MUSD
$25.35MUSDP/E 176.7
$20.69MUSD
$18.82MUSD
$14.75MUSD
$14.58MUSD
$13.43MUSD
$9.21MUSD
$7.52MUSDP/E 12.9
$7.46MUSD
$5.06MUSD
$4.00MUSD
$465.9KUSD
$138.6KUSD
Indicators:|
Key Statistics
Company
Market Cap8.38B $
Enterprise Value8.25B $
Revenue (TTM)763.34M $
Gross Profit386.25M $
Net Income (TTM)48.89M $
Revenue/Share13.56 USD
Last Price148.55 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.0K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS7599161095
Valuation
P/E (Trailing)165.06
P/E (Forward)58.23
PEG2.34
EV/EBITDA61.49
EV/Revenue10.81
P/S10.98
P/B3.98
EPS (TTM)0.90
EPS (Forward)2.55
52W Range
100.9964% of range175.77
52W High175.77 USD
52W Low100.99 USD
Profitability
Gross Margin52.32%
Oper. Margin8.90%
EBITDA Margin17.59%
Profit Margin6.62%
ROE2.32%
ROA1.66%
Growth
Revenue Growth14.80%
Earnings Growth47.90%
Cash Flow & Leverage
Operating CF117.42M $
CapEx (TTM)25.73M $
FCF Margin9.00%
FCF Yield0.82%
Net Debt-96.91M $
Net Debt/EBITDA-0.72
Balance Sheet
Debt/Equity0.33
Current Ratio9.20
Quick Ratio7.45
Book Value/Sh37.33 USD
Cash/Share13.91 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)178.05 USD
Upside (mean)+19.9%
Target Range142.00 USD – 220.00 USD
$142.00+19.9% to mean$220.00
# Analysts20
Ownership
Shares Out.56.41M
Float53.36M
Insiders5.25%
Institutions120.66%
Short Interest
Short Ratio5.5d
Short % Float10.76%
Short % Out.10.72%
Shares Short6.05M
Short (prev mo.)5.96M
Technical
SMA 50127.37 (+16.6%)
SMA 200139.87 (+6.2%)
Beta1.06
S&P 52W Chg20.25%
Avg Vol (30d)957.91K
Avg Vol (10d)742.16K
Technical Indicators
RSI (14)66.5
MACD5.5197
MACD Signal5.1751
MACD Hist.+0.3446
BB Upper153.41 USD
BB Middle139.69 USD
BB Lower125.97 USD
BB Width19.65%
ATR (14)5.721 USD
Vol Ratio (20d)0.83x